Breakthrough for advanced head and neck cancer patients as nivolumab made available on the Cancer Drugs Fund 13 Oct 2017
ICR reacts to decision to make the immunotherapy nivolumab available on the Cancer Drugs Fund for non-small cell lung cancers 20 Sep 2017
New tests select patients who could live for nearly a year longer on targeted bowel cancer drug 08 Aug 2017